Premium
Estrogen receptor status in inflammatory breast carcinoma
Author(s) -
Harvey Harold A.,
Lipton Allan,
Lawrence Bellarmine V.,
White Deborah S.,
Wells Samuel A.,
Blumenschein George,
Lee David
Publication year - 1982
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.2930210111
Subject(s) - medicine , estrogen receptor , estrogen , breast carcinoma , oncology , carcinoma , breast cancer , cancer research , cancer
Sixteen women with a clinical diagnosis of inflammatory breast carcinoma had estrogen receptor analysis performed. Eleven of 16 were premenopausal. Median age of all patients was 46 years. All patients had estrogen receptor (ER) assay by either dextran charcoal method or by sucrose gradient method. Five patients were ER+ (⩾ fmol/mg cytosol protein) and 11 were ER‐, with almost no binding at all. Response to therapy for metastatic disease using either hormones or chemotherapy was disappointing.